0001246360-13-003582.txt : 20130711 0001246360-13-003582.hdr.sgml : 20130711 20130711182808 ACCESSION NUMBER: 0001246360-13-003582 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130710 FILED AS OF DATE: 20130711 DATE AS OF CHANGE: 20130711 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0429 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OConnell Christopher J CENTRAL INDEX KEY: 0001379946 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 13964715 MAIL ADDRESS: STREET 1: MEDTRONIC, INC. STREET 2: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 4 1 form.xml PRIMARY DOCUMENT X0306 4 2013-07-10 false 0000064670 MEDTRONIC INC MDT 0001379946 OConnell Christopher J 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 false true false false EVP & GroupPres Restora Therap Common Stock 2569.291 I ESOP Common Stock 2013-07-10 4 M false 29243 46.01 A 146463.137 D Common Stock 2013-07-10 4 S false 29243 52.8926 D 117220.137 D Common Stock 2013-07-11 4 M false 1186 46.01 A 118406.137 D Common Stock 2013-07-11 4 S false 1186 53.5 D 117220.137 D Employee Stock Option (right to buy) 46.01 2013-07-10 4 M false 29243 0 D 2004-10-23 2013-10-23 Common Stock 30429 1186 D Employee Stock Option (right to buy) 46.01 2013-07-11 4 M false 1186 0 D 2004-10-23 2013-10-23 Common Stock 1186 0 D These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.70 to $53.12 inclusive. The reporting person undertakes to provide to Medtronic, any security holder of Medtronic, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth. This balance increased by 1025.753 shares due to exempt transactions such as dividend reinvestment. Rhonda L. Ingalsbe, Attorney-in-fact 2013-07-11